EUVIMEDEUVIMED entdecken
Crossref

Contribution of Methylenetetrahydrofolate Reductase Genotypes to Brain Tumor Risk Determination in Taiwan

Chao-Hsuan Chen, Chun-Chung Chen, Xian-Xiu Chen, Wen-Shin Chang, Chia-Wen Tsai, Mei-Chin Mong, Shih-Wei Hsu, DA-Tian Bau

Anticancer Research · 2025

DOI: 10.21873/anticanres.17565 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Chao-Hsuan Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, China Medical University Hospital, Taichung, Taiwan, R.O.C. Hauptthemen laut MEDLINE: Methylenetetrahydrofolate Reductase (NADPH2), Brain Neoplasms, Genetic Predisposition to Disease.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methylenetetrahydrofolate Reductase (NADPH2)Brain NeoplasmsGenetic Predisposition to DiseaseHumansFemaleMaleTaiwanCase-Control StudiesMiddle AgedGenotypeAdultPolymorphism, Single NucleotideRisk FactorsAgedGene Frequency

Stichwörter der Autor:innen

Brain tumorTaiwangenotypemethylenetetrahydrofolate reductase (MTHFR)polymorphism

Substanzen

Methylenetetrahydrofolate Reductase (NADPH2)MTHFR protein, human

Autor:innen und Institutionen

  • Department of Neurosurgery, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Department of Surgery, School of Medicine, China Medical University, Taichung, Taiwan, R.O.C.
  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.
  • Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.
  • Department of Food Nutrition and Health Biotechnology, Asia University, Taichung, Taiwan, R.O.C.
  • Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.; hsushihwei690624@gmail.com.

Zitieren

APA

Chen, C. H., Chen, C. C., Chen, X. X., Chang, W. S., Tsai, C. W., Mong, M. C., Hsu, S. W., & Bau, D. T. (2025). Contribution of Methylenetetrahydrofolate Reductase Genotypes to Brain Tumor Risk Determination in Taiwan. Anticancer Research. https://doi.org/10.21873/anticanres.17565

Vancouver

Chen CH, Chen CC, Chen XX, Chang WS, Tsai CW, Mong MC, et al. Contribution of Methylenetetrahydrofolate Reductase Genotypes to Brain Tumor Risk Determination in Taiwan. Anticancer Research. 2025. doi:10.21873/anticanres.17565

BibTeX
@article{Chen2025,
  author = {Chen, Chao-Hsuan and Chen, Chun-Chung and Chen, Xian-Xiu and Chang, Wen-Shin and Tsai, Chia-Wen and Mong, Mei-Chin and Hsu, Shih-Wei and Bau, DA-Tian},
  title = {Contribution of Methylenetetrahydrofolate Reductase Genotypes to Brain Tumor Risk Determination in Taiwan},
  journal = {Anticancer Research},
  year = {2025},
  doi = {10.21873/anticanres.17565}
}
Kostenlos starten →